⚕️
Sağlık Hizmetleri Sektörü Hisseleri
Sağlık Hizmetleri Sektörü altında 807 Hisse Senedi
Sağlık Hizmetleri sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$5.6T
Toplam Piyasa Değeri
Sağlık Hizmetleri Sektörü Hisseleri
Sayfa 1/9 (Toplam: 807)
SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
---|---|---|---|---|
LLY | Eli Lilly and Company | $697.04B | $776.44 | 1.87% |
JNJ | Johnson & Johnson | $404.05B | $167.93 | 2.17% |
ABBV | AbbVie Inc. | $330.51B | $187.11 | 1.22% |
UNH | UnitedHealth Group Incorporated | $258.65B | $285.13 | 1.06% |
ABT | Abbott Laboratories | $218.75B | $125.73 | 1.05% |
MRK | Merck & Co., Inc. | $204.93B | $81.61 | 2.90% |
ISRG | Intuitive Surgical, Inc. | $183.15B | $511.00 | 0.99% |
AMGN | Amgen Inc. | $164.37B | $305.69 | 3.32% |
TMO | Thermo Fisher Scientific Inc. | $161.42B | $427.62 | 5.60% |
BSX | Boston Scientific Corporation | $152.62B | $103.16 | 0.60% |
SYK | Stryker Corporation | $151.01B | $395.15 | 2.02% |
PFE | Pfizer Inc. | $142.93B | $25.14 | 3.63% |
GILD | Gilead Sciences, Inc. | $137.04B | $110.17 | 1.75% |
DHR | Danaher Corporation | $135.91B | $189.91 | 0.98% |
VRTX | Vertex Pharmaceuticals Incorporated | $120.73B | $470.13 | 2.54% |
MDT | Medtronic plc | $117.43B | $91.65 | 2.17% |
WELL | Welltower Inc. | $105.35B | $161.09 | 0.48% |
BMY | Bristol-Myers Squibb Company | $97.72B | $48.02 | 2.85% |
MCK | McKesson Corporation | $88.62B | $709.47 | 0.24% |
HCA | HCA Healthcare, Inc. | $84.43B | $350.97 | 3.73% |
CI | Cigna Corporation | $80.16B | $300.05 | 1.78% |
CVS | CVS Health Corporation | $77.27B | $61.08 | 0.91% |
ZTS | Zoetis Inc. | $67.31B | $151.19 | 2.59% |
ELV | Elevance Health Inc. | $63.44B | $281.72 | 1.91% |
REGN | Regeneron Pharmaceuticals, Inc. | $59.54B | $560.93 | 2.82% |
COR | Cencora, Inc. | $56.78B | $292.97 | 0.10% |
BDX | Becton, Dickinson and Company | $51.96B | $181.28 | 3.39% |
VEEV | Veeva Systems Inc. | $46.61B | $285.20 | 1.49% |
EW | Edwards Lifesciences Corporation | $44.76B | $76.30 | 0.33% |
IDXX | IDEXX Laboratories, Inc. | $42.78B | $532.00 | 2.14% |
ALNY | Alnylam Pharmaceuticals, Inc. | $42.41B | $325.28 | 1.49% |
RMD | ResMed Inc. | $39.21B | $267.40 | 2.42% |
CAH | Cardinal Health, Inc. | $37.50B | $157.10 | 0.93% |
GEHC | GE HealthCare Technologies Inc. | $35.02B | $76.49 | 3.13% |
DXCM | DexCom, Inc. | $33.38B | $85.12 | 1.30% |
A | Agilent Technologies, Inc. | $33.01B | $116.19 | 3.70% |
IQV | IQVIA Holdings Inc. | $32.42B | $187.38 | 17.88% |
VTR | Ventas, Inc. | $30.29B | $67.11 | 1.01% |
HUM | Humana Inc. | $27.89B | $231.12 | 3.44% |
STE | STERIS plc | $22.00B | $223.69 | 0.47% |
LH | Laboratory Corporation of America Holdings | $21.09B | $252.07 | 3.72% |
PODD | Insulet Corporation | $20.10B | $285.57 | 1.64% |
DGX | Quest Diagnostics Incorporated | $19.90B | $178.24 | 7.08% |
INSM | Insmed Incorporated | $19.55B | $102.92 | 0.14% |
NTRA | Natera, Inc. | $19.11B | $139.92 | 0.50% |
ZBH | Zimmer Biomet Holdings, Inc. | $19.10B | $96.52 | 4.24% |
BIIB | Biogen Inc. | $18.73B | $127.85 | 4.21% |
WAT | Waters Corporation | $17.11B | $287.46 | 2.06% |
ILMN | Illumina, Inc. | $16.15B | $102.03 | 7.63% |
WST | West Pharmaceutical Services, Inc. | $15.73B | $218.90 | 4.20% |
COO | The Cooper Companies, Inc. | $14.57B | $73.03 | 2.40% |
HOLX | Hologic, Inc. | $14.57B | $65.37 | 2.64% |
THC | Tenet Healthcare Corporation | $14.49B | $155.97 | 10.70% |
BAX | Baxter International Inc. | $14.12B | $27.51 | 0.51% |
ALGN | Align Technology, Inc. | $14.07B | $194.06 | 2.67% |
WPC | W. P. Carey Inc. | $13.95B | $63.72 | 3.06% |
CNC | Centene Corporation | $13.88B | $27.89 | 1.68% |
MEDP | Medpace Holdings, Inc. | $13.73B | $477.73 | 54.67% |
UTHR | United Therapeutics Corporation | $13.44B | $297.89 | 1.63% |
INCY | Incyte Corporation | $13.34B | $68.90 | 2.26% |
DOC | Healthpeak Properties, Inc. | $13.19B | $18.99 | 3.21% |
NBIX | Neurocrine Biosciences, Inc. | $13.14B | $132.75 | 0.70% |
MRNA | Moderna, Inc. | $12.66B | $32.73 | 5.68% |
SOLV | Solventum Corporation | $12.62B | $72.92 | 0.80% |
EXEL | Exelixis, Inc. | $12.13B | $44.47 | 0.47% |
BMRN | BioMarin Pharmaceutical Inc. | $11.35B | $59.20 | 4.67% |
RVTY | Revvity, Inc. | $11.33B | $96.13 | 5.96% |
OHI | Omega Healthcare Investors, Inc. | $11.18B | $38.63 | 1.52% |
DOCS | Doximity, Inc. | $11.15B | $59.38 | 1.44% |
SCI | Service Corporation International | $11.12B | $78.14 | 1.45% |
DVA | DaVita Inc. | $11.03B | $146.05 | 4.75% |
EHC | Encompass Health Corporation | $10.93B | $108.39 | 1.46% |
VTRS | Viatris Inc. | $10.84B | $9.24 | 3.82% |
HIMS | Hims & Hers Health, Inc. | $10.77B | $50.01 | 5.06% |
ATR | AptarGroup, Inc. | $10.51B | $159.17 | 2.39% |
UHS | Universal Health Services, Inc. | $10.48B | $162.68 | 3.60% |
TEM | Tempus AI, Inc. | $10.27B | $61.08 | 5.29% |
WBA | Walgreens Boots Alliance, Inc. | $9.99B | $11.54 | 0.17% |
MOH | Molina Healthcare, Inc. | $9.79B | $180.64 | 2.38% |
PLNT | Planet Fitness, Inc. | $9.52B | $113.55 | 3.21% |
EXAS | Exact Sciences Corporation | $9.40B | $49.83 | 3.04% |
PEN | Penumbra, Inc. | $8.98B | $231.88 | 1.32% |
AVTR | Avantor, Inc. | $8.87B | $13.02 | 5.53% |
HSIC | Henry Schein, Inc. | $8.79B | $72.20 | 4.53% |
BBIO | BridgeBio Pharma, Inc. | $8.69B | $45.77 | 0.28% |
MASI | Masimo Corporation | $8.58B | $158.23 | 2.00% |
HQY | HealthEquity, Inc. | $8.42B | $97.41 | 0.34% |
BPMC | Blueprint Medicines Corporation | $8.36B | $129.46 | 0.14% |
TECH | Bio-Techne Corporation | $8.33B | $53.12 | 5.67% |
CRL | Charles River Laboratories International, Inc. | $8.02B | $163.36 | 9.06% |
ENSG | The Ensign Group, Inc. | $7.84B | $136.36 | 0.70% |
VNO | Vornado Realty Trust | $7.63B | $39.77 | 2.71% |
ELAN | Elanco Animal Health Incorporated | $7.41B | $14.93 | 1.70% |
CORT | Corcept Therapeutics Incorporated | $7.33B | $69.08 | 1.48% |
GMED | Globus Medical, Inc. | $7.18B | $53.01 | 2.16% |
RVMD | Revolution Medicines, Inc. | $7.13B | $38.27 | 0.39% |
HALO | Halozyme Therapeutics, Inc. | $7.09B | $57.54 | 2.91% |
MDGL | Madrigal Pharmaceuticals, Inc. | $6.96B | $313.40 | 5.30% |
BIO | Bio-Rad Laboratories, Inc. | $6.68B | $245.47 | 0.50% |
IONS | Ionis Pharmaceuticals, Inc. | $6.68B | $41.95 | 0.96% |